• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,741.82 238.22
( 0.31%)
Global Indices
Nasdaq
52,357.11 -589.04
(-1.11%)
Dow Jones
7,503.65 -21.20
(-0.28%)
Hang Seng
67,966.49 1,147.44
(1.72%)
Nikkei 225
10,472.08 -16.96
(-0.16%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540025
INE837H01020
63.3737836
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADVENZYMES
26.37
3561.4
EPS(TTM)
Face Value()
Div & Yield %
12.06
2
0.42
 

Nava consolidated net profit declines 45.77% in the March 2026 quarter
May 15,2026
Net profit of Nava declined 45.77% to Rs 127.13 crore in the quarter ended March 2026 as against Rs 234.41 crore during the previous quarter ended March 2025. Sales rose 12.24% to Rs 1142.85 crore in the quarter ended March 2026 as against Rs 1018.20 crore during the previous quarter ended March 2025.

For the full year,net profit declined 27.93% to Rs 786.67 crore in the year ended March 2026 as against Rs 1091.48 crore during the previous year ended March 2025. Sales rose 7.72% to Rs 4290.92 crore in the year ended March 2026 as against Rs 3983.55 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1142.851018.20 12 4290.923983.55 8
OPM %32.4837.48 -40.0246.07 -
PBDT416.12414.45 0 1893.211960.90 -3
PBT325.33324.31 0 1502.021608.49 -7
NP127.13234.41 -46 786.671091.48 -28